September 2018 - Page 4 of 4 - Corcept Therapeutics

Antiglucocorticoid therapy for older adults with anxiety and co-occurring cognitive dysfunction: results from a pilot study with mifepristone.

September 18, 2018

Lenze et al. • 2014 • Int J Geriatr Psychiatry. 2014;29(9):962-9.

Rapid reversal of acute psychosis in the Cushing syndrome with the cortisol-receptor antagonist mifepristone (RU 486).

September 18, 2018

van der Lely et al. • 1991 • Ann Intern Med. 1991;114(2):143-4.

1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as potent GR antagonists with reduced hERG inhibition and an improved pharmacokinetic profile.

September 18, 2018

Hunt et al. • 2015 • Bioorg Med Chem Lett. 2015;25(24):5720-5.

Comparison of direct action of thiazolidinediones and glucocorticoids on renal podocytes: protection from injury and molecular effects.

September 18, 2018

Agrawal et al. • 2011 • Mol Pharmacol. 2011;80(3):389-99.

Administration of a selective glucocorticoid antagonist attenuates electroconvulsive shock-induced retrograde amnesia.

September 18, 2018

Andrade et al. • 2012 • J Neural Transm (Vienna). 2012;119(3):337-44.